Australia Stock Exchange release from DIMERIX : Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
10/01/2022 22:50
Australia Stock Exchange release from DIMERIX DXB.AX : Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions